Authors


Rebekah Bernard, MD

Latest:

A physician’s advice for defusing patient anger

Rebekah Bernard, MD, provides tips for improving interactions with patients who are angry.


Max Schloemann

Latest:

Urology Practice advice: prioritize billing and coding oversight

When a miscoded procedure is the result of substantial negligence or fraud, it can be detrimental to a medical practice or physician.


Sujith Puskoor, DO

Latest:

PARP inhibitors: Treating mCRPC from a genetic basis

Treatments provide a targeted therapeutic strategy for metastatic castration-resistant prostate cancer.


Andrew G. McIntosh, MD

Latest:

Radical nephrectomy before or after systemic therapy for mRCC

Recent research has revived the controversy regarding the role of cytoreductive nephrectomy in this setting.


Brandon Daniell

Latest:

How text messaging can be a valuable tool for your practice

Here are seven ways texting can improve healthcare revenue and decrease costs.


Bryan S. Sack, MD

Latest:

Integrating video visits into urologic training

"Now is the time for programs to leverage their existing telehealth platforms and practices for trainee education while continuing to serve patients," the authors write.


Kyle Doherty

Latest:

Abemaciclib trial misses end point, but supports targeting CDK4/6 in mCRPC

The CDK4/6 inhibitor abemaciclib showed clinically activity in patients with heavily pretreated metastatic castration-resistant prostate cancer.


Cynthia Sener, MBA

Latest:

Managing your online reputation in health care

While online reviews are critical in any industry, patient expectations are simply different when it comes to health care.


Will Pizii

Latest:

Neoadjuvant chemoimmunotherapy combo shows promise in UTUC

The phase 2 study explored the combination of the PD-1 inhibitor toripalimab and chemotherapy as neoadjuvant treatment for patients with upper tract urothelial carcinoma.


University Hospitals

Latest:

University Hospitals Cleveland Medical Center named first SpaceOAR Hydrogel Center of Excellence

The device helps reduce unintentional side effects of prostate cancer therapy.


Allina Health Cancer Institute

Latest:

Allina Health Cancer Institute 2022 Symposium reimagines cancer care

The symposium brings together clinicians devoted to solving the disease of cancer and the many challenges associated with it.


Richard G. Harris, MD, FACS

Latest:

Letter: Declassifying Gleason 6 as a cancer would do more harm than good

"We feel a more appropriate approach would be to retain true Gleason 6 as a cancer of extremely low metastatic potential requiring close follow-up," write Harris et al.


Jamie Cesanek

Latest:

Abiraterone-based triplet boosts survival in de novo mCSPC

Findings from the PEACE-1 trial published in the Lancet showed that adding abiraterone acetate and prednisone to androgen-deprivation therapy and docetaxel improved overall survival in patients with de novo metastatic castration-sensitive prostate cancer.


Jennifer A. Linehan, MD

Latest:

Why favor high intensity focused ultrasound for treating localized prostate cancer?

"HIFU allows us to treat where we want and not where we don’t," writes Jennifer Linehan, MD.


Michael Parisi

Latest:

Smaller medical practices increasingly targeted for cyber attacks

Patient data is so valuable — and smaller providers are more vulnerable — that hackers are increasingly targeting physician groups.


Nichole Tucker

Latest:

Study signals benefit with maintenance darolutamide in mCRPC

Patients in the trial received switch maintenance with darolutamide following prior taxane chemotherapy and at least 1 androgen-receptor pathway inhibitor.


Joan Naidorf, DO

Latest:

Expert advice on improving interactions with difficult patients

“Patients will never change, and demanding family members will never change. The solution to the problem is to manage the way we think about them,” writes Joan Naidorf, DO.


Nancy B. Davis, MD

Latest:

BCG-unresponsive NMIBC: Current evidence and options

Multiple investigational agents have been developed and are being studied.



Austin Richards

Latest:

Malpractice Consult: What you should know about jury selection

Here are some ways in which lawyers can remove potential jurors from a case.


Bobby Liaw, MD

Latest:

Future Directions for the Management of Advanced Prostate Cancer

Bobby Liaw, MD; Vivek K. Narayan, MD, MS; Ashley E. Ross, MD, PhD; and Neal Shore, MD, FACS, provide closing thoughts and advice for the optimal management of advanced prostate cancer.


Russ Conroy

Latest:

Bladder-sparing trimodal therapy yields similar results as radical cystectomy in MIBC

The 5-year metastasis-free survival rate was 75% with trimodality therapy vs 74% with radical cystectomy.


UCSF Health

Latest:

UCSF Department of Urology Grand Rounds with Dr. Ezekiel J. Emanuel: October 14

Join the discussion on Health Reform with world leader in health policy and bioethics, Ezekiel J. Emanuel, MD, PhD, the Vice Provost for Global Initiatives and expert panelists and UCSF leaders.


Daniel C. Parker, MD

Latest:

How to perform office-based blue light cystoscopy

BLC with hexaminolevulinate can be an easily replicable procedure in patients with non–muscle-invasive bladder cancer.


Jim Tudor, PCA, CPC

Latest:

Trends in coding audits and what physicians can expect

Recent trends in medical audits and what physicians can expect with the CMS changes in 2021 to the documentation of E/M codes.


Daniel D. Joyce, MD

Latest:

Transurethral resection of the bladder tumor: Standard technique and new advancements

Improvement in imaging modalities may help in performance of transurethral resection of the bladder tumor.


Lee Barrett

Latest:

Smaller medical practices increasingly targeted for cyber attacks

Patient data is so valuable — and smaller providers are more vulnerable — that hackers are increasingly targeting physician groups.


Shawn Dickerson

Latest:

Expert shares key cybersecurity fundamentals and best practices

Cybersecurity training is vital because it is mandated by HIPAA.


Vivek K. Narayan, MD, MS

Latest:

Future Directions for the Management of Advanced Prostate Cancer

Bobby Liaw, MD; Vivek K. Narayan, MD, MS; Ashley E. Ross, MD, PhD; and Neal Shore, MD, FACS, provide closing thoughts and advice for the optimal management of advanced prostate cancer.


© 2023 MJH Life Sciences

All rights reserved.